The parathyroid hormone receptorsome and the potential for therapeutic intervention

Current Drug Targets

Volumn 13, Issue 1, 2012, Pages 116-128

  Mahon, M J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Arrestins; Calmodulin; Calpain; Ezrin; G proteins; NHERF 1 and 2; Osteoporosis; Parathyroid hormone; Parathyroid hormone 1 receptor

Indexed keywords

ARGININE; CALMODULIN; CALPAIN; EZRIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; LYSINE; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE RELATED PROTEIN; PDZ PROTEIN; PHOSPHATE; PROTEIN NHERF 1; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL SPECIFICITY; COMPLEX FORMATION; CYTOSOL; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HORMONE RECEPTOR INTERACTION; HUMAN; KIDNEY PROXIMAL TUBULE; NONHUMAN; OSTEOPOROSIS; PROTEIN DOMAIN; PROTEIN MOTIF; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SENSOR; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; ENDOSOMES; HOMEOSTASIS; HUMANS; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; OSTEOPOROSIS; PARATHYROID GLANDS; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECEPTOR, PARATHYROID HORMONE, TYPE 1; SIGNAL TRANSDUCTION;

EID: 84855846095     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945012798868416     Document Type: Article

References (112)

1. Mannstadt M, Jüppner H, Gardella T. Receptors for PTH and PTHrP: their biological importance and functional properties. Am J Physiol 1999; 277: F665-75.
2. Qian J, Colbert MC, Witte D, et al. Midgestational lethality in mice lacking the parathyroid hormone (PTH)/PTH-related peptide receptor is associated with abrupt cardiomyocyte death. Endocrinology 2003; 144(3): 1053-61.
3. Schwindinger WF, Fredericks J, Watkins L, et al. Coupling of the PTH/PTHrP receptor to multiple G-proteins. Direct demonstration of receptor activation of Gs, Gq/11, and Gi(1) by [alpha-32P]GTPgamma-azidoanilide photoaffinity labeling. Endocrine 1998; 8(2): 201-9.
4. Bringhurst FR, Jüppner H, Guo J, et al. Cloned, stably expressed parathyroid hormone (PTH)/PTH-related peptide receptors activate multiple messenger signals and biological responses in LLC-PK1 kidney cells. Endocrinology 1993; 132(5): 2090-2098.
5. Miyauchi A, Dobre V, Rickmeyer M, Cole J, Forte L, Hruska KA. Stimulation of transient elevations in cytosolic Ca2+ is related to inhibition of Pi transport in OK cells. Am J Physiol 1990; 259(3 Pt 2): F485-93.
6. Smogorzewski M, Zayed M, Zhang YB, Roe J, Massry SG. Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes. Am J Physiol 1993; 264(6 Pt 2): H1998-2006.
7. Fadda GZ, Thanakitcharu P, Smogorzewski M, Massry SG. Parathyroid hormone raises cytosolic calcium in pancreatic islets: study on mechanisms. Kidney Int 1993; 43(3): 554-60.
8. Tanaka H, Smogorzewski M, Koss M, Massry SG. Pathways involved in PTH-induced rise in cytosolic Ca2+ concentration of rat renal proximal tubule. Am J Physiol 1995; 268(2 Pt 2): F330-7.
9. Mahon M, Segre G. Stimulation by parathyroid hormone of a NHERF-1-assembled complex consisting of the parathyroid hormone I receptor, phospholipase Cbeta, and actin increases intracellular calcium in opossum kidney cells. J Biol Chem 2004; 279: 23550-8.
10. Cole JA. Parathyroid hormone activates mitogen-activated protein kinase in opossum kidney cells. Endocrinology 1999; 140(12): 5771-9.
11. Singh AT, Gilchrist A, Voyno-Yasenetskaya T, Radeff-Huang JM, Stern PH. G alpha12/G alpha13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells. Endocrinology 2005; 146(5): 2171-5.
12. Kalinowski L, Dobrucki LW, Malinski T. Nitric oxide as a second messenger in parathyroid hormone-related protein signaling. J Endocrinol 2001; 170(2): 433-40.
13. Sutliff RL, Weber CS, Qian J, Miller ML, Clemens TL, Paul RJ. Vasorelaxant properties of parathyroid hormone-related protein in the mouse: evidence for endothelium involvement independent of nitric oxide formation. Endocrinology 1999; 140(5): 2077-83.
14. Huang Z, Chen Y, Pratt S, et al. The N-terminal region of the third intracellular loop of the parathyroid hormone (PTH)/PTH-related peptide receptor is critical for coupling to cAMP and inositol phosphate/Ca2++ signal transduction pathways. J Biol Chem 1996; 271: 33382-9.
15. Iida-Klein A, Guo J, Takamura M, et al. Mutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTHrelated protein receptor result in selective loss of PTH-stimulated phospholipase C activity. J Biol Chem 1997; 272: 6882-9.
16. Sakmar TP, Menon ST, Marin EP, Awad ES. Rhodopsin: insights from recent structural studies. Annu Rev Biophys Biomol Struct 2002; 31: 443-84.
17. Daaka Y, Luttrell LM, Lefkowitz RJ. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 1997; 390(6655): 88-91.
18. Iida-Klein A, Guo J, Xie LY, et al. Truncation of the carboxylterminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor enhances PTH stimulation of adenylate cyclase but not phospholipase C. J Biol Chem 1995; 270: 8458-65.
19. Mahon MJ, Shimada M. Calmodulin interacts with the cytoplasmic tails of the parathyroid hormone 1 receptor and a sub-set of class b G-protein coupled receptors. FEBS Lett 2005; 579(3): 803-7.
20. Mahon MJ, Bonacci TM, Divieti P, Smrcka AV. A docking site for G protein betagamma subunits on the parathyroid hormone 1 receptor supports signaling through multiple pathways. Mol Endocrinol 2006; 20(1): 136-46.
21. Shimada M, Mahon MJ, Greer PA, Segre GV. The receptor for parathyroid hormone and parathyroid hormone-related peptide is hydrolyzed and its signaling properties are altered by directly binding the calpain small subunit. Endocrinology 2005; 146(5): 2336-44.
22. El Far O, Bofill-Cardona E, Airas JM, et al. Mapping of calmodulin and Gbetagamma binding domains within the Cterminal region of the metabotropic glutamate receptor 7A. J Biol Chem 2001; 276(33): 30662-9.
23. Li Y, Sternweis PM, Charnecki S, et al. Sites for Galpha binding on the G protein beta subunit overlap with sites for regulation of phospholipase Cbeta and adenylyl cyclase. J Biol Chem 1998; 273(26): 16265-72.
24. Johnston CA, Kimple AJ, Giguere PM, Siderovski DP. Structure of the parathyroid hormone receptor C terminus bound to the Gprotein dimer Gbeta1gamma2. Structure 2008; 16(7): 1086-94.
25. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev 2003; 83(3): 731-801.
26. Lebart MC, Benyamin Y. Calpain involvement in the remodeling of cytoskeletal anchorage complexes. FEBS J 2006; 273(15): 3415-26.
27. Yao X, Thibodeau A, Forte JG. Ezrin-calpain I interactions in gastric parietal cells. Am J Physiol 1993; 265(1 Pt 1): C36-46.
28. Murray SS, Grisanti MS, Bentley GV, Kahn AJ, Urist MR, Murray EJ. The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells. Exp Cell Res 1997; 233(2): 297-309.
29. Murray EJ, Tram KK, Murray SS, Lee DB. Parathyroid hormoneinduced retraction of MC3T3-E1 osteoblastic cells is attenuated by the calpain inhibitor N-Ac-Leu-Leu-norleucinal. Metabolism 1995; 44(2): 141-4.
30. Murray EJ, Tram KK, Spencer MJ, Tidball JG, Murray SS, Lee DB. PTH-mediated osteoblast retraction: possible participation of the calpain pathway. Miner Electrolyte Metab 1995; 21(1-3): 184-8.
31. Shimada M, Greer PA, McMahon AP, Bouxsein ML, Schipani E. In vivo targeted deletion of calpain small subunit, Capn4, in cells of the osteoblast lineage impairs cell proliferation, differentiation, and bone formation. J Biol Chem 2008; 283(30): 21002-10.
32. Kashiwagi A, Schipani E, Fein MJ, Greer PA, Shimada M. Targeted deletion of Capn4 in cells of the chondrocyte lineage impairs chondrocyte proliferation and differentiation. Mol Cell Biol 2010; 30(11): 2799-810.
33. Means AR. The Year in Basic Science: calmodulin kinase cascades. Mol Endocrinol 2008; 22(12): 2759-65.
34. Rhoads AR, Friedberg F. Sequence motifs for calmodulin recognition. Faseb J 1997; 11(5): 331-40.
35. Yanagawa N, Jo OD. Possible role of calcium in parathyroid hormone actions in rabbit renal proximal tubules. Am J Physiol 1986; 250(5 Pt 2): F942-8.
36. Goligorsky MS, Menton DN, Hruska KA. Parathyroid hormoneinduced changes of the brush border membrane topography and cytosketelon in cultured renal proximal tubular cells. J Membr Biol 1986; 92: 151-62.
37. Mooseker MS, Bonder EM, Conzelman KA, Fishkind DJ, Howe CL, Keller TC, 3rd. Brush border cytoskeleton and integration of cellular functions. J Cell Biol 1984; 99(1 Pt 2): 104s-112s.
38. Quinn CO, Rajakumar RA, Agapova OA. Parathyroid hormone induces rat interstitial collagenase mRNA through Ets-1 facilitated by cyclic AMP response element-binding protein and Ca(2+)/calmodulin-dependent protein kinase II in osteoblastic cells. J Mol Endocrinol 2000; 25(1): 73-84.
39. Ferrari S, Behar V, Chorev M, Rosenblatt M, Bisello A. Endocytosis of Ligand-Human Parathyroid Hormone Receptor 1 Complexes Is Protein Kinase C-dependent and Involves-Arrestin2. J Biol Chem 1999; 274: 29968-75.
40. Tawfeek HA, Qian F, Abou-Samra AB. Phosphorylation of the receptor for PTH and PTHrP is required for internalization and regulates receptor signaling. Mol Endocrinol 2002; 16(1): 1-13.
41. Vilardaga JP, Krasel C, Chauvin S, Bambino T, Lohse MJ, Nissenson RA. Internalization determinants of the parathyroid hormone receptor differentially regulate beta-arrestin/receptor association. J Biol Chem 2002; 277(10): 8121-9.
42. Tawfeek HA, Che J, Qian F, Abou-Samra AB. Parathyroid hormone receptor internalization is independent of protein kinase A and phospholipase C activation. Am J Physiol Endocrinol Metab 2001; 281(3): E545-57.
43. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins. Science 2005; 308(5721): 512-7.
44. Gesty-Palmer D, Chen M, Reiter E, et al. Distinct beta-arrestinand G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J Biol Chem 2006; 281(16): 10856-64.
45. Rey A, Manen D, Rizzoli R, Caverzasio J, Ferrari SL. Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with betaarrestin2 for ERK1/2 activation. J Biol Chem 2006; 281(50): 38181-8.
46. Mahon M, Donowitz M, Yun C, Segre G. Na(+)/H(+) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling. Nature 2002; 417: 858-61.
47. Harris BZ, Lim WA. Mechanism and role of PDZ domains in signaling complex assembly. J Cell Sci 2001; 114(Pt 18): 3219-31.
48. Bezprozvanny I, Maximov A. Classification of PDZ domains. FEBS Lett 2001; 509(3): 457-62.
49. Shenolikar S, Voltz JW, Cunningham R, Weinman EJ. Regulation of ion transport by the NHERF family of PDZ proteins. Physiology (Bethesda) 2004; 19: 362-9.
50. Reczek D, Bretscher A. The carboxyl-terminal region of EBP50 binds to a site in the amino-terminal domain of ezrin that is masked in the dormant molecule. J Biol Chem 1998; 273(29): 18452-8.
51. Reczek D, Berryman M, Bretscher A. Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J Cell Biol 1997; 139(1): 169-79.
52. Wang S, Raab RW, Schatz PJ, Guggino WB, Li M. Peptide binding consensus of the NHE-RF-PDZ1 domain matches the C-terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR). FEBS Lett 1998; 427(1): 103-8.
53. Tang Y, Tang J, Chen Z, et al. Association of mammalian trp4 and phospholipase C isozymes with a PDZ domain-containing protein, NHERF. J Biol Chem 2000; 275(48): 37559-64.
54. Wang B, Ardura JA, Romero G, Yang YS, Hall RA, Friedman PA. Na/H exchanger regulatory factors control PTH receptor signaling by facilitating differential activation of G{alpha} protein subunits. J Biol Chem 2010; 285: 26976-86.
55. Orloff JJ, Kats Y, Urena P, et al. Further evidence for a novel receptor for amino-terminal parathyroid hormone-related protein on keratinocytes and squamous carcinoma cell lines. Endocrinology 1995; 136: 3016-23.
56. Gaich G, Orloff JJ, Atillasoy EJ, Burtis WJ, Ganz MB, Stewart AF. Amino-terminal parathyroid hormone-related portein: specific binding and cytosolic calcium responses in rat insulinoma cells. Endocrinology 1993; 132: 1402-9.
57. Schluter KD, Weber M, Piper HM. Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. Biochem J 1995; 310 (Pt 2): 439-44.
58. McCauley LK, Rosol TJ, Merryman JI, Capen CC. Parathyroid hormone-related protein binding to human T-cell lymphotropic virus type I-infected lymphocytes. Endocrinology 1992; 130(1): 300-6.
59. Sneddon WB, Syme CA, Bisello A, et al. Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50). J Biol Chem 2003; 278(44): 43787-96.
60. Friedman PA, Goodman WG. PTH(1-84)/PTH(7-84): a balance of power. Am J Physiol Renal Physiol 2006; 290(5): F975-84.
61. Wang B, Bisello A, Yang Y, Romero GG, Friedman PA. NHERF1 regulates parathyroid hormone receptor membrane retention without affecting recycling. J Biol Chem 2007; 282(50): 36214-22.
62. Wheeler D, Garrido JL, Bisello A, Kim YK, Friedman PA, Romero G. Regulation of parathyroid hormone type 1 receptor dynamics, traffic, and signaling by the Na+/H+ exchanger regulatory factor-1 in rat osteosarcoma ROS 17/2.8 cells. Mol Endocrinol 2008; 22(5): 1163-70.
63. Wheeler D, Sneddon WB, Wang B, Friedman PA, Romero G. NHERF-1 and the cytoskeleton regulate the traffic and membrane dynamics of G protein-coupled receptors. J Biol Chem 2007; 282(34): 25076-87.
64. Wang B, Yang Y, Abou-Samra AB, Friedman PA. NHERF1 regulates parathyroid hormone receptor desensitization: interference with beta-arrestin binding. Mol Pharmacol 2009; 75(5): 1189-97.
65. Klenk C, Vetter T, Zurn A, et al. Formation of a ternary complex between NHERF1, {beta}-arrestin, and parathyroid hormone receptor. J Biol Chem 2010; 285: 30355-62.
66. Wade JB, Welling PA, Donowitz M, Shenolikar S, Weinman EJ. Differential renal distribution of NHERF isoforms and their colocalization with NHE3, ezrin, and ROMK. Am J Physiol Cell Physiol 2001; 280(1): C192-8.
67. Hall RA, Premont RT, Chow CW, et al. The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature 1998; 392(6676): 626-30.
68. Amizuka N, Lee HS, Khan MY, et al. Cell-specific expression of the parathyroid hormone (PTH)PTH-related peptide receptor gene in kidney from kidney-specific and ubiquitous promotors. Endocrinology 1997; 138: 469-81.
69. Ba J, Brown D, Friedman PA. Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. Am J Physiol Renal Physiol 2003; 285(6): F1233-43.
70. Capuano P, Bacic D, Roos M, et al. Defective coupling of apical PTH receptors to phospholipase C prevents internalization of the Na+-phosphate cotransporter NaPi-IIa in Nherf1-deficient mice. Am J Physiol Cell Physiol 2007; 292(2): C927-34.
71. Bretscher A, Chambers D, Nguyen R, Reczek D. ERM-Merlin and EBP50 protein families in plasma membrane organization and function. Annu Rev Cell Dev Biol 2000; 16: 113-43.
72. Yonemura S, Hirao M, Doi Y, Takahashi N, Kondo T, Tsukita S. Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol 1998; 140(4): 885-95.
73. Cha B, Tse M, Yun C, et al. The NHE3 juxtamembrane cytoplasmic domain directly binds ezrin: dual role in NHE3 trafficking and mobility in the brush border. Mol Biol Cell 2006; 17(6): 2661-73.
74. Mahon MJ. The parathyroid hormone 1 receptor directly binds to the FERM domain of ezrin, an interaction that supports apical receptor localization and signaling in LLC-PK1 cells. Mol Endocrinol 2009; 23(10): 1691-701.
75. Tenenhouse H. Regulation of phosphorus homeostasis by the type IIa Na/phosphate cotransporter. Annu Rev Nutr 2005; 25: 197-214.
76. Gisler SM, Stagljar I, Traebert M, Bacic D, Biber J, Murer H. Interaction of the type IIa Na/Pi cotransporter with PDZ proteins. J Biol Chem 2001; 276(12): 9206-13.
77. Hernando N, Deliot N, Gisler SM, et al. PDZ-domain interactions and apical expression of type IIa Na/P(i) cotransporters. Proc Natl Acad Sci U S A 2002; 99(18): 11957-62.
78. Shenolikar S, Voltz JW, Minkoff CM, Wade JB, Weinman EJ. Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting. Proc Natl Acad Sci U S A 2002; 99(17): 11470-5.
79. Mahon MJ. Ezrin promotes functional expression and parathyroid hormone-mediated regulation of the sodium-phosphate cotransporter 2a in LLC-PK1 cells. Am J Physiol Renal Physiol 2008; 294(3): F667-75.
80. Cole JA, Forte LR, Krause WJ, Thorne PK. Clonal sublines that are morphologically and functionally distinct from parental OK cells. Am J Physiol 1989; 256(4 Pt 2): F672-9.
81. Mahon MJ, Cole JA, Lederer ED, Segre GV. Na+/H+ exchangerregulatory factor 1 mediates inhibition of phosphate transport by parathyroid hormone and second messengers by acting at multiple sites in opossum kidney cells. Mol Endocrinol 2003; 17(11): 2355-64.
82. Cunningham R, Steplock D, E X, et al. Adenoviral expression of NHERF-1 in NHERF-1 null mouse renal proximal tubule cells restores Npt2a regulation by low phosphate media and parathyroid hormone. Am J Physiol Renal Physiol 2006; 291(4): F896-901.
83. Weinman EJ, Biswas RS, Peng Q, et al. Parathyroid hormone inhibits renal phosphate transport by phosphorylation of serine 77 of sodium-hydrogen exchanger regulatory factor-1. J Clin Invest 2007; 117(11): 3412-20.
84. Blaine J, Okamura K, Giral H, et al. PTH-induced internalization of apical membrane NaPi2a: role of actin and myosin VI. Am J Physiol Cell Physiol 2009; 297(6): C1339-46.
85. Egan JJ, Gronowicz G, Rodan GA. Parathyroid hormone promotes the disassembly of cytoskeletal actin and myosin in cultured osteoblastic cells: mediation by cyclic AMP. J Cell Biochem 1991; 45(1): 101-11.
86. Dransfield DT, Bradford AJ, Smith J, et al. Ezrin is a cyclic AMPdependent protein kinase anchoring protein. Embo J 1997; 16(1): 35-43.
87. Sugai M, Saito M, Sukegawa I, et al. PTH/PTH-related protein receptor interacts directly with Tctex-1 through its COOH terminus. Biochem Biophys Res Commun 2003; 311(1): 24-31.
88. Karcher RL, Deacon SW, Gelfand VI. Motor-cargo interactions: the key to transport specificity. Trends Cell Biol 2002; 12(1): 21-7.
89. Tai AW, Chuang JZ, Bode C, Wolfrum U, Sung CH. Rhodopsin's carboxy-terminal cytoplasmic tail acts as a membrane receptor for cytoplasmic dynein by binding to the dynein light chain Tctex-1. Cell 1999; 97(7): 877-87.
90. Stow JL, Sabolic I, Brown D. Heterogeneous localization of G protein alpha-subunits in rat kidney. Am J Physiol 1991; 261(5 Pt 2): F831-40.
91. Zheng S, Yu P, Zeng C, et al. Galpha12-and Galpha13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension 2003; 41(3): 604-10.
92. Lea JP, Ertoy D, Hollis JL, Marrero MB, Sands JM. Immunolocalization of phospholipase C isoforms in rat kidney. Kidney Int 1998; 54(5): 1484-90.
93. Sato T, Garcia-Bunuel R, Brandes D. Ultrastructural cytochemical localization of adenylate cyclase in the rat nephron. Lab Invest 1974; 30(2): 222-9.
94. Bauer W, Aub JC, Albright F. Studies of calcium and phosphorus metabolism: V. A study of the bone trabeculae as a readily available reserve supply of calcium. J Exp Med 1929; 49(1): 145-62.
95. Slovik DM, Neer RM, Potts JT, Jr. Short-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients. J Clin Invest 1981; 68(5): 1261-71.
96. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344(19): 1434-41.
97. Blick SK, Dhillon S, Keam SJ. Teriparatide: a review of its use in osteoporosis. Drugs 2008; 68(18): 2709-37.
98. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425(6960): 841-6.
99. Adams GB, Martin RP, Alley IR, et al. Therapeutic targeting of a stem cell niche. Nat Biotechnol 2007; 25(2): 238-43.
100. Ballen KK, Shpall EJ, Avigan D, et al. Phase I trial of parathyroid hormone to facilitate stem cell mobilization. Biol Blood Marrow Transplant 2007; 13(7): 838-43.
101. Ballen K. Targeting the stem cell niche: squeezing blood from bones. Bone Marrow Transplant 2007; 39(11): 655-60.
102. Dean T, Vilardaga JP, Potts JT, Jr., Gardella TJ. Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor. Mol Endocrinol 2008; 22(1): 156-66.
103. Potts JT, Gardella TJ. Progress, paradox, and potential: parathyroid hormone research over five decades. Ann N Y Acad Sci 2007; 1117: 196-208.
104. Okazaki M, Ferrandon S, Vilardaga JP, Bouxsein ML, Potts JT Jr., Gardella TJ. Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation. Proc Natl Acad Sci U S A 2008; 105(43): 16525-30.
105. Takasu H, Gardella TJ, Luck MD, Potts JT, Jr., Bringhurst FR. Amino-terminal modifications of human parathyroid hormone (PTH) selectively alter phospholipase C signaling via the type 1 PTH receptor: implications for design of signal-specific PTH ligands. Biochemistry 1999; 38(41): 13453-60.
106. Bisello A, Chorev M, Rosenblatt M, Monticelli L, Mierke DF, Ferrari SL. Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations. J Biol Chem 2002; 277(41): 38524-30.
107. Gesty-Palmer D, Flannery P, Yuan L, et al. A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci Transl Med 2009; 1(1): 1ra1.
108. Arkin MR, Wells JA. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 2004; 3(4): 301-17.
109. Fujii N, Haresco JJ, Novak KA, et al. Rational design of a nonpeptide general chemical scaffold for reversible inhibition of PDZ domain interactions. Bioorg Med Chem Lett 2007; 17(2): 549-52.
110. Fujii N, Haresco JJ, Novak KA, Stokoe D, Kuntz ID, Guy RK. A selective irreversible inhibitor targeting a PDZ protein interaction domain. J Am Chem Soc 2003; 125(40): 12074-5.
111. Thorsen TS, Madsen KL, Rebola N, et al. Identification of a smallmolecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTD. Proc Natl Acad Sci USA 2010; 107(1): 413-8.
112. Zhang W, Penmatsa H, Ren A, et al. Functional regulation of CFTR-containing macromolecular complexes: a small-molecule inhibitor approach. Biochem J 2011; 435(2): 451-62.